Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Storti

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Clinical Chemistry and Laboratory Medicine|January 19, 2002
Molecular characterization of chromosome 22 deletions by short tandem repeat polymorphism (STRP) in patients with conotruncal heart defectsS Vittorini, M Sacchelli, M R Iascone, et al.
Peptides|October 15, 2013
C-type natriuretic peptide plasma levels are reduced in obese adolescentsS Del Ry, M Cabiati, V Bianchi, et al.
Annals of the Rheumatic Diseases|April 1, 1990
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluationM Magarò, A Zoli, L Altomonte, et al.
Haematologica|November 1, 1993
Autologous transplantation of peripheral blood progenitor cells mobilized by chemotherapy with or without G-CSF (filgrastim) in resistant lymphoproliferative diseases: enhanced hemopoietic recovery with filgrastim primed progenitorsS Sica, P Salutari, A Di Mario, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2007
Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemiaL Fianchi, L Pagano, F Leoni, et al.
Blood|June 1, 1997
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphomaP L Zinzani, E Pavone, S Storti, et al.
Haematologica|December 20, 1999
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?P L Zinzani, M Martelli, M Magagnoli, et al.
Blood|June 25, 1999
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patientsP L Zinzani, S Storti, A Zaccaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patientsP L Zinzani, F Gherlinzoni, S Storti, et al.
Leukemia|November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II TrialA Cortelezzi, M Sciumè, A M Liberati, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Clinical Chemistry and Laboratory Medicine|January 19, 2002
Molecular characterization of chromosome 22 deletions by short tandem repeat polymorphism (STRP) in patients with conotruncal heart defectsS Vittorini, M Sacchelli, M R Iascone, et al.
Peptides|October 15, 2013
C-type natriuretic peptide plasma levels are reduced in obese adolescentsS Del Ry, M Cabiati, V Bianchi, et al.
Annals of the Rheumatic Diseases|April 1, 1990
Iron chelation in rheumatoid arthritis: clinical and laboratory evaluationM Magarò, A Zoli, L Altomonte, et al.
Haematologica|November 1, 1993
Autologous transplantation of peripheral blood progenitor cells mobilized by chemotherapy with or without G-CSF (filgrastim) in resistant lymphoproliferative diseases: enhanced hemopoietic recovery with filgrastim primed progenitorsS Sica, P Salutari, A Di Mario, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2007
Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemiaL Fianchi, L Pagano, F Leoni, et al.
Blood|June 1, 1997
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphomaP L Zinzani, E Pavone, S Storti, et al.
Haematologica|December 20, 1999
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?P L Zinzani, M Martelli, M Magagnoli, et al.
Blood|June 25, 1999
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patientsP L Zinzani, S Storti, A Zaccaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patientsP L Zinzani, F Gherlinzoni, S Storti, et al.
Leukemia|November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II TrialA Cortelezzi, M Sciumè, A M Liberati, et al.
Pageof 7